We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > inflammatory bowel disease

News List

Arena 3 for 3 as Crohn’s drug meets proof-of-concept test fiercebiotech
September 27, 2018
The data shows that olorinab warrants further development, an analyst says.
DPP-4 inhibitors may be linked to inflammatory bowel disease europeanpharmaceuticalreview
March 26, 2018
The use of certain diabetes drugs, known as dipeptidyl peptidase-4 inhibitors, are associated with an increased risk of inflammatory bowel disease…
Connect Biopharmaceuticals Completes $25 Million Financing to Advance Clinical Development of Novel firstwordpharma
January 25, 2017
Connect Biopharmaceuticals, Ltd., a clinical-stage company that discovers and develops novel immune modulators for the treatment of autoimmune diseases and cancer, today announces the completion of a $20 million Series A financing.